Research

Energy balance

AMPK activation reduces liver fat accumulation by downregulating lipid synthesis genes (FAS, SREBP-1c, ACC, HMGCR) and upregulating fatty acid oxidation genes (CPT1, PGC1, HSL, ATGL).

Understanding the specific genes involved (like CPT1 for burning fat and FAS for making fat) helps explain why metabolic health is complex. Interventions that activate AMPK can shift this balance.

ModerateSupportsMEDIUM confidence
In NAFLD and AFLD, increasing the activity of AMPK can inhibit the synthesis of fatty acids and cholesterol by down-regulating the expression of adipogenesis gene (FAS, SREBP-1c, ACC and HMGCR); Simultaneously, by increasing the expression of fatty acid oxidation and lipid decomposition genes (CPT1, PGC1, and HSL, ATGL) involved in fatty acid oxidation and lipid decomposition, the body’s natural lipid balance can be maintained.
Chunqiu Fang et al. · Frontiers in Physiology · 2022

Why this rating

Based on review of animal models and molecular studies.

Source

The AMPK pathway in fatty liver disease

Chunqiu Fang et al. · Frontiers in Physiology · 2022

DOI 10.3389/fphys.2022.970292

narrative_reviewCited 335×
Read the paper
DOI resolved against Crossref · corpus check 2026-06-10

This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →